TP53 and neoplasm: The overexpression of these genes elevated Hsp90ab1, calreticulin, Ppib, Trail and p53 in their CMs as well as downregulated tumor-promoting cytokines such as CXCL2 and LIF as well as PDL1, a target of anti-PD1 immunotherapy.